Luxembourg Bio Technologies

Set up in 2008, Luxembourg Bio Technologies gradually affirms its place in the world biotech field. This company particularly generates and commercializes components and chemicals for peptide synthesis, the procedure by which peptide bonds are taken shape from amino acids.

Luxembourg Bio Technologies completely opts for making use of green chemistry and sustainable methods if possible. At a similar time, a variety of its products are designed to be compatible with environmentally friendly conditions. In addition, this company always operates under the most rigorous quality assurance standards to provide the customers with the best possible products, including COMU, HDMC, OxymaPure, DEPBT, and EDC.HCL, and many others. Its services and products are being applied in a wide range of areas, such as peptide, oligonucleotide, and nanoparticle synthesis.

On top of that, many subsidiaries of Luxembourg Bio Technologies also collaborate with amenities across Europe to not only conduct laboratory-scale experiments but also multi-litre reactions for other organizations that do not own production plants to carry out their pilot projects. Simultaneously, this institution certainly pays close attention to the demands of the economy and environment to achieve optimal solutions. As a modern industrial operative, Luxembourg Bio Technologies strives to preserve and protect the environment and to consider the outcomes of the industrial field, in order to create an efficient and eco-friendly industry for generations.

Founded: 2008

Headquarters: Nes Ziona, Luxembourg
Website: https://www.luxembourg-bio.com/